Targeting DYRK1A with rationally designed pyrazine–guanidine hybrids for Alzheimer's disease: design, synthesis, and biological evaluation
- DOI
- 10.1039/d6ra06655k
- Published
- 2026
- Container
- RSC Advances
- Publisher
- Royal Society of Chemistry (RSC)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1039/d6ra06655k,
title = {Targeting DYRK1A with rationally designed pyrazine–guanidine hybrids for Alzheimer's disease: design, synthesis, and biological evaluation},
author = {Sabiha Khan and Sumaiya Khan and Shafa Khan and Md. Ataur Rahman and Abdur Rahman and Aquib Reza and Shilpi Khurana and Mohammad Zahid Ashraf and Asimul Islam and Nasimul Hoda},
year = {2026},
journal = {RSC Advances},
doi = {10.1039/d6ra06655k},
url = {https://doi.org/10.1039/d6ra06655k}
}RIS
TY - JOUR TI - Targeting DYRK1A with rationally designed pyrazine–guanidine hybrids for Alzheimer's disease: design, synthesis, and biological evaluation AU - Sabiha Khan AU - Sumaiya Khan AU - Shafa Khan AU - Md. Ataur Rahman AU - Abdur Rahman AU - Aquib Reza AU - Shilpi Khurana AU - Mohammad Zahid Ashraf AU - Asimul Islam AU - Nasimul Hoda PY - 2026 JO - RSC Advances DO - 10.1039/d6ra06655k UR - https://doi.org/10.1039/d6ra06655k ER -
APA
Khan, S., Khan, S., Khan, S., Rahman, M. A., Rahman, A., Reza, A., Khurana, S., Ashraf, M. Z., Islam, A., & Hoda, N. (2026). Targeting DYRK1A with rationally designed pyrazine–guanidine hybrids for Alzheimer's disease: design, synthesis, and biological evaluation. RSC Advances. https://doi.org/10.1039/d6ra06655k
Source records
- crossref · retrieved 2026-11-08T15:07:09.425Z